| 1 |
32238729 | Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus. | 2020 Jul 13 |
1 |
| 2 |
31411059 | Moderate hyperoxia induces senescence in developing human lung fibroblasts. | 2019 Nov 1 |
1 |
| 3 |
25890358 | TNFα sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-induced cell death by NF-κB-mediated expression of Fas. | 2015 Mar 19 |
5 |
| 4 |
21555371 | TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. | 2011 Jul 1 |
1 |
| 5 |
22027829 | Monocyte-specific accessibility of a matrix attachment region in the tumor necrosis factor locus. | 2011 Dec 23 |
1 |
| 6 |
20237821 | Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner. | 2010 Jul |
1 |
| 7 |
15273737 | Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. | 2004 Sep 2 |
1 |
| 8 |
15507659 | EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. | 2004 Nov |
1 |
| 9 |
12815281 | cDNA array analysis of alterations in gene expression in the promyelocytic leukemia cell line, HL-60, after apoptosis induction with etoposide. | 2003 Aug |
1 |
| 10 |
12207175 | Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways. | 2002 Oct |
1 |
| 11 |
11244505 | Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells. | 2001 Jan 4 |
2 |
| 12 |
10440872 | Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis. | 1999 Sep 15 |
1 |
| 13 |
10092213 | Expression of HSP27 results in increased sensitivity to tumor necrosis factor, etoposide, and H2O2 in an oxidative stress-resistant cell line. | 1998 Dec |
1 |
| 14 |
8858979 | Endogenous tumor necrosis factor enhances topoisomerase II inhibitors activity in human ovarian cancer cell lines. | 1996 Oct |
1 |
| 15 |
7597304 | Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology. | 1995 |
1 |
| 16 |
7654031 | Sensitization of human glioblastoma T98G cells to VP16 and VM26 by human tumor necrosis factor. | 1995 Jul-Aug |
2 |
| 17 |
1336489 | Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation. | 1992 Nov |
1 |
| 18 |
1779333 | Chemoimmunotherapy in conjunction with surgery: strategies for management of murine neuroblastoma. | 1991 Oct |
2 |
| 19 |
2166714 | Effects of tumor necrosis factor, alone or in combination with topoisomerase-II-targeted drugs, on human lung cancer cell lines. | 1990 Aug 15 |
1 |
| 20 |
2171561 | Interaction of recombinant human tumor necrosis factor and etoposide in human lung cancer cell lines. | 1990 Sep |
3 |
| 21 |
2219586 | Enhanced in vivo cytotoxicity of recombinant human tumor necrosis factor with etoposide in human renal cell carcinoma. Evaluation in a pre-clinical model. | 1990 |
1 |